EHA 2026: H.C. Wainwright Senior Biotech Analyst Mitchell Kapoor previews key EHA data from Legend and Incyte, and shares catalysts he is watching for after the conference

3 hours ago
1 min read

He discusses in vivo CAR-T data from Legend, and how Incyte is planning for the loss of exclusivity on Jakafi. Plus, his take on last week's summit data, and watching out for future catalysts from Ionis and Tyra.

Recent Posts

See All

At Nucleate UK's The Forum in London, former Novo Nordisk CSO Marcus Schindler reflects on the success of the GLPs and shares advice for biotech entrepreneurs in Europe

At Nucleate UK's The Forum, early stage biotech investor Nirmesh Patel of Amino Collective says there is currently a bifurcation in fundraising between biotech co's with an AI angle and those without

At Nucleate UK's The Forum 2026, Oxford Nanopore Founder Gordon Sanghera shares his take on the next generation of biotech leaders and the innovation ecosystem in the UK

EHA 2026: H.C. Wainwright Senior Biotech Analyst Mitchell Kapoor previews key EHA data from Legend and Incyte, and shares catalysts he is watching for after the conference

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight